With the spread of coronavirus epidemic and the strengthening of consumer health awareness, Bright Dairy has discovered the market and consumer needs. As the leading strength in the field of probiotic research and development, Bright Dairy has developed and launched the Bright JCAN series of probiotics, which use the double benefit live formula of IgG immunoglobulin + probiotics and contain over 30 billion CFU live bacteria per bag. This also marked an important step of Bright Dairy towards the big health. In 2020, Bright Dairy entered into a strategic cooperation agreement with Shanghai Pharma, in which both parties will work together to develop new ideas for the application of functional probiotics and jointly innovate functional strains and dairy products. (Source: ce.cn)

Comments are closed.